Zinzino Soars on Acquisition Blitz, Proposes 50% Dividend Hike

GOTHENBURG, Sweden – February 25, 2026 – Global health and wellness company Zinzino AB has capped a transformative year with the announcement of record-breaking financial results for 2025, driven by an aggressive acquisition strategy that has significantly expanded its global footprint. The company reported a staggering 51% increase in annual revenue and a substantial boost in profitability, prompting its Board of Directors to propose a 50% hike in the shareholder dividend to SEK 6.00 per share.

The remarkable performance underscores a period of intense strategic activity for the direct-sales firm, which has been systematically acquiring competitors to bolster its distribution network, particularly in the lucrative North and South American markets.

A Record-Breaking Financial Performance

Zinzino's year-end report paints a picture of explosive growth. For the full year 2025, total revenues surged to SEK 3,337.5 million, a 51% increase from the SEK 2,207.8 million reported in the previous year. This growth accelerated in the final quarter, where revenues hit SEK 1,035.3 million—a 45% jump year-over-year and the first time in the company's history that quarterly revenue surpassed the SEK 1 billion mark.

Profitability metrics were equally impressive. Full-year EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) rose to SEK 443.4 million, lifting the EBITDA margin to 13.3% from 11.4% in 2024. The fourth quarter was particularly strong, with an EBITDA of SEK 175.2 million and a margin of 16.9%, a significant improvement over the 10.2% margin in the same period last year. The company attributed this enhanced profitability primarily to stronger gross profits and synergies realized from recent acquisitions, most notably the integration of Zurvita.

This robust financial health translated directly into shareholder value, with net profit for the year nearly doubling to SEK 324.5 million. The proposed dividend increase is a clear signal of the board's confidence in sustained future earnings and a commitment to rewarding its investors.

The Acquisition Engine Fuels Global Expansion

The story behind Zinzino's 2025 success is one of strategic, high-velocity expansion through mergers and acquisitions. The company has been on a buying spree, absorbing the assets of several direct-sales companies to rapidly scale its operations.

A key contributor to the year's results was the integration of Zurvita's assets, an acquisition completed early in 2025 that solidified Zinzino's presence in North America. The positive impact of this move was especially evident in the fourth quarter's improved margins. The company continued this push into the Americas by acquiring the assets of Sanki, a move explicitly designed to enhance distribution power across both North and South America.

The pace has not slowed in the new year. Zinzino announced a significant post-reporting date event: the acquisition of It Works!. This deal is expected to add over USD 60 million in revenue for 2026 and further strengthen the company’s distribution capabilities in North America and Europe. This pattern of acquiring and integrating distributor networks from other direct-sales firms like Bodē Pro and Truvy has become a core pillar of its growth model, allowing for rapid market penetration.

Analysts have noted this strategy of funding acquisitions primarily through the issuance of new shares. While this can lead to share dilution, the approach is seen as a strategic trade-off that enables economies of scale and long-term profitability, ultimately benefiting all shareholders as the company grows.

Innovation in Sustainability and Product Diversification

Beyond its aggressive M&A activities, Zinzino is also making strategic investments in its supply chain and product portfolio to secure long-term, sustainable growth. In a significant move, the company acquired a 35% stake in Xion International Group during the fourth quarter. This partnership is aimed at producing algae using bioreactors, a cutting-edge method to secure a sustainable and future-proof supply of omega-3.

This investment directly supports Zinzino's flagship product, BalanceOil, and positions the company as a forward-thinker in an industry grappling with the environmental impact of traditional sourcing methods like wild-caught fish. By shifting towards a controlled, algae-based production system, Zinzino not only secures its supply chain but also builds a powerful competitive advantage by appealing to an increasingly eco-conscious consumer base.

The company also demonstrated its ability to innovate and tap into new market trends with the successful launch of its Gut Health Test. The product saw immediate traction, selling over 60,000 units within a month of its debut in the third quarter. This expansion into the burgeoning field of personalized nutrition and gut microbiome analysis diversifies Zinzino's offerings and opens up a significant new revenue stream, complementing its core focus on omega-3 supplements.

While the market has reacted positively to the strong results and confident dividend outlook, some analysts are closely watching the company's ability to maintain organic growth. Initial figures for January 2026 suggested a moderation in the growth rate, highlighting the ongoing challenge of seamlessly integrating multiple acquired businesses while also fostering growth from within its existing operations. Nevertheless, with ambitious financial targets set through 2028, including an average sales growth of at least 20% and an EBITDA margin above 11%, Zinzino has signaled its clear intention to continue its aggressive drive for market leadership in the global health and wellness sector.